ArticleJAAD international2024

Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study.

Xue Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.